MRVINasdaq United States
Market cap
$1.609 B
$6.23 -0.32%
Close of 7 Aug 2026
Revenue
$185.7M
#2319 by revenue
Earnings
-$130.8M
Loss-making
Shares outstanding
—
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Maravai Lifesciences are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.